Dimensional Fund Advisors
ADMS

Dimensional Fund Advisors’s Adamas Pharmaceuticals ADMS Stock Holding History

Dimensional Fund Advisors’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-205,519
Closed -$594K – 3374
2020
Q1 		$594K Hold
205,519
– – ﹤0.01% 3022
2019
Q4 		$779K Buy
205,519
+56,430
+38% +$270K ﹤0.01% 3061
2019
Q3 		$763K Sell
149,089
-1,980
-1% -$12.2K ﹤0.01% 3065
2019
Q2 		$937K Hold
151,069
– – ﹤0.01% 3064
2019
Q1 		$1.07M Buy
151,069
+40,731
+37% +$366K ﹤0.01% 3017
2018
Q4 		$942K Hold
110,338
– – ﹤0.01% 3025
2018
Q3 		$2.21M Buy
+110,338
New +$2.59M ﹤0.01% 2910
2018
Q1 		– Sell
-137,524
Closed -$4.66M – 3363
2017
Q4 		$4.66M Sell
137,524
-700
-0.5% -$19.5K ﹤0.01% 2650
2017
Q3 		$2.93M Sell
138,224
-2,257
-2% -$41.4K ﹤0.01% 2763
2017
Q2 		$2.46M Buy
140,481
+14,987
+12% +$248K ﹤0.01% 2807
2017
Q1 		$2.2M Sell
125,494
-1,000
-0.8% -$17K ﹤0.01% 2823
2016
Q4 		$2.14M Buy
126,494
+28,994
+30% +$448K ﹤0.01% 2800
2016
Q3 		$1.6M Buy
97,500
+36,950
+61% +$562K ﹤0.01% 2835
2016
Q2 		$917K Buy
60,550
+1,300
+2% +$21.4K ﹤0.01% 2947
2016
Q1 		$857K Sell
59,250
-10,161
-15% -$171K ﹤0.01% 2949
2015
Q4 		$1.97M Buy
69,411
+59,285
+585% +$998K ﹤0.01% 2818
2015
Q3 		$170K Buy
+10,126
New +$230K ﹤0.01% 3255

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors's ADMS Position: Q2 2020 in Review

Dimensional Fund Advisors sold out of Adamas Pharmaceuticals (ADMS) in Q2 2020, closing a stake of 205,519 shares — an estimated $594K sold.

Dimensional Fund Advisors first reported a position in ADMS in Q3 2015 and held it in 17 quarters. The position peaked at $4.66M in Q4 2017. 61 funds tracked by Wall St. Rank hold ADMS as of Q2 2020.

  • Dimensional Fund Advisors reported no remaining Adamas Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 205,519 Adamas Pharmaceuticals shares in Q2 2020, an estimated $594K.
  • Dimensional Fund Advisors first reported a position in Adamas Pharmaceuticals in Q3 2015 and held it in 17 quarters.
  • Dimensional Fund Advisors's Adamas Pharmaceuticals position peaked at $4.66M in Q4 2017.
  • 61 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2020.

Based on Dimensional Fund Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.